申请人:Balasubramanian Gopalan
公开号:US20110257164A1
公开(公告)日:2011-10-20
Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors.
本发明涉及一类新化合物,其化学式为(I),以及它们的衍生物、类似物、互变异构体、区域异构体、立体异构体、多晶形态、溶剂化物、中间体、药学上可接受的盐、制药组合物、代谢物和前药。这些化合物能够有效降低血糖、血清胰岛素、游离脂肪酸、胆固醇、甘油三酯水平;用于肥胖、炎症、自身免疫疾病如多发性硬化症、类风湿性关节炎的治疗;以及用于治疗和/或预防2型糖尿病。这些化合物特别是二肽基肽酶(DPP IV)抑制剂。